6.4.6 Shedding and Secondary Exposure

Recommendations

The testimonies and the 2023 NCI Report highlight the need for:

Immediately Discontinuing Use of mRNA vaccines.
Comprehensive Shedding Studies: Conduct detailed studies on the shedding of vaccine-derived materials to understand the full scope and impact of secondary exposure.
Transparent Communication: Ensure that information about the risks of shedding and secondary exposure is transparently communicated to the public to support Informed Consent.
Regulatory Oversight: Strengthen regulatory oversight to mandate shedding studies for new vaccines and ensure that the results are publicly accessible.
Public Health Guidelines: Develop public health guidelines to mitigate the risks associated with shedding, particularly for vulnerable populations.

Addressing these concerns is crucial for maintaining public trust and ensuring that vaccine policies are based on comprehensive scientific evidence, safeguarding both individual and public health.

Report Content Reader Page

📄 Note to Readers

The content presented on this page has been adapted for online viewing and navigation. Due to formatting limitations within the web display system, certain elements—such as layout, spacing, and visual structure—may differ slightly from the original report.

For the complete and fully formatted version, we encourage you to download the official PDF available on the Report Information page. The PDF reflects the report exactly as it was originally written and published.